These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20662692)
1. Contrast-induced nephropathy after a second contrast exposure. Trivedi H; Foley WD Ren Fail; 2010; 32(7):796-801. PubMed ID: 20662692 [TBL] [Abstract][Full Text] [Related]
2. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Solomon R; Dumouchel W Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749 [TBL] [Abstract][Full Text] [Related]
3. Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. Kim KS; Kim K; Hwang SS; Jo YH; Lee CC; Kim TY; Rhee JE; Suh GJ; Singer AJ; Kim HD Am J Emerg Med; 2011 May; 29(4):412-7. PubMed ID: 20825813 [TBL] [Abstract][Full Text] [Related]
4. A Retrospective Review of Contrast Nephropathy in a General Population. Arayan A; Nigogosyan MA; Van Every MJ WMJ; 2015 Jun; 114(3):95-9. PubMed ID: 27073827 [TBL] [Abstract][Full Text] [Related]
5. [Contrast-induced nephropathy after computer tomography. Hydration and adapted contrast media dosage for the best prophylaxis]. Haglund M; Hesselstrand R; Nyman U; Sterner G Lakartidningen; 2005 Oct 3-9; 102(40):2864-6, 2869-70. PubMed ID: 16255363 [No Abstract] [Full Text] [Related]
6. Small-bowel angioedema during screening computed tomography due to intravenous contrast material. Park SW; Bae IY; Eun HW; Park HW; Choe JW J Comput Assist Tomogr; 2011; 35(5):549-52. PubMed ID: 21926847 [TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous contrast agents for CT studies in children. Cohen MD; Herman E; Herron D; White SJ; Smith JA Acta Radiol; 1992 Nov; 33(6):592-5. PubMed ID: 1449887 [TBL] [Abstract][Full Text] [Related]
8. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. LaBounty TM; Shah M; Raman SV; Lin FY; Berman DS; Min JK Am J Cardiol; 2012 Jun; 109(11):1594-9. PubMed ID: 22440116 [TBL] [Abstract][Full Text] [Related]
9. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide]. Schmiedel E Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014 [TBL] [Abstract][Full Text] [Related]
10. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol. Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138 [TBL] [Abstract][Full Text] [Related]
11. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study]. Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455 [TBL] [Abstract][Full Text] [Related]
13. Drug eruption caused by nonionic iodinated X-ray contrast media. Akiyama M; Nakada T; Sueki H; Fujisawa R; Iijima M Acad Radiol; 1998 Apr; 5 Suppl 1():S159-61. PubMed ID: 9561070 [No Abstract] [Full Text] [Related]
14. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy. Chicaíza-Becerra LA; García-Molina M; Gamboa Ó Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291 [TBL] [Abstract][Full Text] [Related]
15. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization. Pinès E; Zamia P; Idée JM J Invasive Cardiol; 2005 Feb; 17(2):123-4. PubMed ID: 15770762 [No Abstract] [Full Text] [Related]
16. Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare. Mitchell AM; Jones AE; Tumlin JA; Kline JA Acad Emerg Med; 2011 Sep; 18(9):1005-9. PubMed ID: 21854485 [TBL] [Abstract][Full Text] [Related]
17. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization. Gayet JL; Lefevre T J Invasive Cardiol; 2005 Feb; 17(2):124. PubMed ID: 15770763 [No Abstract] [Full Text] [Related]
18. Preventing Intravenous Contrast Extravasation in CT: A Simple Solution. Conner B; Ash R; Allen W; Brown T; Hill J; Hook M; Fishback S J Am Coll Radiol; 2017 Oct; 14(10):1326-1332. PubMed ID: 28739321 [No Abstract] [Full Text] [Related]
19. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization. Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875 [TBL] [Abstract][Full Text] [Related]
20. Incidence of contrast-induced nephropathy with volume supplementation--insights from a large cohort. Mueller-Lenke N; Buerkle G; Klima T; Breidthardt T; Buettner HJ; Mueller C Med Princ Pract; 2008; 17(5):409-14. PubMed ID: 18685283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]